Related references
Note: Only part of the references are listed.Vasculogenic mimicry, a complex and devious process favoring tumorigenesis-Interest in making it a therapeutic target
Lucas Treps et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling
Ji-Gang Zhang et al.
BMC CANCER (2020)
uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines
Alessio Biagioni et al.
CELLS (2020)
An Overview of Vasculogenic Mimicry in Breast Cancer
Marco A. Andonegui-Elguera et al.
FRONTIERS IN ONCOLOGY (2020)
Angiogenesis Analyzer for ImageJ - A comparative morphometric analysis of Endothelial Tube Formation Assay and Fibrin Bead Assay
Gilles Carpentier et al.
SCIENTIFIC REPORTS (2020)
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells
Elena Andreucci et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma
Hao-fan Wang et al.
CELL PROLIFERATION (2019)
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells
Anna Laurenzana et al.
EBIOMEDICINE (2019)
Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry
Xue Zhang et al.
JOURNAL OF CANCER (2019)
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
Ami Hori et al.
BREAST CANCER RESEARCH (2019)
Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
Cornelis Bisschop et al.
MELANOMA RESEARCH (2018)
BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers
Jaquelyn N. Sanchez et al.
DRUGS (2018)
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
Sunilkumar Kakadia et al.
ONCOTARGETS AND THERAPY (2018)
Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents
Amalia Vartanian et al.
MELANOMA RESEARCH (2017)
Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
Daniel Delgado-Bellido et al.
MOLECULAR CANCER (2017)
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH
Jessica Ruzzolini et al.
CANCER LETTERS (2017)
Tumour acidosis: from the passenger to the driver's seat
Cyril Corbet et al.
NATURE REVIEWS CANCER (2017)
Overcoming resistance to BRAF inhibitors
Imanol Arozarena et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
The NC11 domain of human collagen XVI induces vasculogenic mimicry in oral squamous cell carcinoma cells
Konstanze B. Bedal et al.
CARCINOGENESIS (2015)
Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer
Yanlei Li et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells
Silvia Peppicelli et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis
Zhifei Cao et al.
EUROPEAN JOURNAL OF CANCER (2013)
Molecular Pathways: Vasculogenic Mimicry in Tumor Cells: Diagnostic and Therapeutic Implications
Dawn A. Kirschmann et al.
CLINICAL CANCER RESEARCH (2012)
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval
Salvatore Ulisse et al.
CLINICAL ENDOCRINOLOGY (2012)
Measuring Tumor Aggressiveness and Targeting Metastatic Lesions with Fluorescent pHLIP
Yana K. Reshetnyak et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Dysregulated pH: a perfect storm for cancer progression
Bradley A. Webb et al.
NATURE REVIEWS CANCER (2011)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Hypoxia and metabolism - Opinion - A microenvironmental model of carcinogenesis
Robert A. Gatenby et al.
NATURE REVIEWS CANCER (2008)
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness
Jolanta M. Topczewska et al.
NATURE MEDICINE (2006)
Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry
EA Seftor et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix
AJ Maniotis et al.
LABORATORY INVESTIGATION (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Regulation of urokinase/urokinase receptor interaction by heparin-like glycosaminoglycans
M Pucci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
